SYNCHRON Systems Direct LDL Cholesterol (LDLD) Reagent, REF: 969706

FDA Device Recall #Z-0441-2026 - Class II, September 17, 2025

Recall Summary

Recall Number Z-0441-2026
Classification Class II - Moderate risk
Date Initiated September 17, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Beckman Coulter Inc.
Location Brea, CA
Product Type Devices
Quantity 2,932 units

Product Description

SYNCHRON Systems Direct LDL Cholesterol (LDLD) Reagent, REF: 969706

Reason for Recall

Beckman Coulter has identified that there is an increased probability Synchron Systems Direct LDL Cholesterol (LDLD REF 969706) reagent lot M404166 may generate false high results. The issue was discovered internally and confirmed on August 19, 2025 by Beckman Coulter.

Distribution Pattern

Worldwide - US Nationwide distribution in the states of AL, AR, CA, FL, GA, HI, IA, ID, KS, KY, LA, MA, MD, ME, MI, MO, MS, NC, NE, NJ, NM, NY, OH, OK, OR, PA, PR, QC, SC, TX, WA, WV and the country of Canada.

Lot / Code Information

REF: 969706. Lot: M404166. Expiration Date: 30Nov2025

Other Recalls from Beckman Coulter Inc.

Recall # Classification Product Date
Z-2974-2026 Class II Beckman Coulter DxC 500 AU Clinical Analyzer Mo... Jul 15, 2026
Z-2973-2026 Class II Beckman Coulter DxC 500i Clinical Analyzer Modu... Jul 15, 2026
Z-2889-2026 Class II REF # D23354, MicroScan LabPro V5.03 Panel Upda... Jun 26, 2026
Z-2888-2026 Class II REF # D23352, MicroScan LabPro V5.03 Panel Upda... Jun 26, 2026
Z-0541-2026 Class II DxFLEX Flow Cytometer Catalog Number C78500 UD... Sep 22, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.